31 July 2020: Clinical Research
Peripheral Absolute Lymphocyte Count: An Economical and Clinical Available Immune-Related Prognostic Marker for Newly Diagnosed Multiple Myeloma
Ying Yang AEF , Zhuogang Liu ABC , Hongtao Wang ACEG*DOI: 10.12659/MSM.923716
Med Sci Monit 2020; 26:e923716
Figure 1 (A) ALC <1.43×109/L predicted shorter OS. (B) LMR <3.7 predicted shorter OS. (C) Patients in L-ISS stage III were predicted to have shorter OS. (D) Patients in late stage of L-ISS were predicted to have shorter OS. (E) Patients in late stage of ISS predicted to have shorter OS.